| Curcumin |
NCT03085680 |
Completed |
Phase 2|Phase 3 |
Curcumin and Function in Older Adults |
Older Adults|Physical Function|Cognitive Function |
https://ClinicalTrials.gov/show/NCT03085680 |
| Curcumin |
NCT02944578 |
Recruiting |
Phase 2 |
Topical Curcumin for Precancer Cervical Lesions |
Neoplasms |
https://ClinicalTrials.gov/show/NCT02944578 |
| Curcumin |
NCT03211104 |
Completed |
Not Applicable |
Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy |
Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03211104 |
| Curcumin |
NCT03980509 |
Recruiting |
Phase 1 |
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors |
Breast Cancer |
https://ClinicalTrials.gov/show/NCT03980509 |
| Curcumin |
NCT04012424 |
Not yet recruiting |
Not Applicable |
The Effect of Premedication With Curcumin on Post-endodontic Pain |
Acute Pulpitis |
https://ClinicalTrials.gov/show/NCT04012424 |
| Curcumin |
NCT03790605 |
Recruiting |
Phase 3 |
A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis |
Periodontitis |
https://ClinicalTrials.gov/show/NCT03790605 |
| Curcumin |
NCT03568513 |
Recruiting |
Not Applicable |
Effect of Curcumin on Gut Microbiota in IBS |
Irritable Bowel Syndrome |
https://ClinicalTrials.gov/show/NCT03568513 |
| Curcumin |
NCT02321293 |
Unknown status |
Phase 1 |
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC |
Lung Cancer |
https://ClinicalTrials.gov/show/NCT02321293 |
| Curcumin |
NCT02476708 |
Terminated |
Not Applicable |
A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia |
Schizophrenia|Schizoaffective Disorder |
https://ClinicalTrials.gov/show/NCT02476708 |
| Curcumin |
NCT03864783 |
Recruiting |
Not Applicable |
The Effect of Curcumin on Liver Fat Content in Obese Subjects |
Non-Alcoholic Fatty Liver Disease|Insulin Resistance|Glucose Tolerance Impaired|Obesity, Abdominal |
https://ClinicalTrials.gov/show/NCT03864783 |
| Curcumin |
NCT01543386 |
Completed |
Phase 1|Phase 2 |
Effects of Curcumin on Vascular Reactivity |
Healthy Volunteers (Middle-aged Smokers) |
https://ClinicalTrials.gov/show/NCT01543386 |
| Curcumin |
NCT03122613 |
Recruiting |
Not Applicable |
Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis |
Ulcerative Colitis in Remission |
https://ClinicalTrials.gov/show/NCT03122613 |
| Curcumin |
NCT02645656 |
Unknown status |
Phase 2 |
Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) |
Oral Submucous Fibrosis |
https://ClinicalTrials.gov/show/NCT02645656 |
| Curcumin |
NCT04032132 |
Completed |
Phase 4 |
Curcumin Paste as an Adjunctive Therapy in Periodontitis |
Periodontitis |
https://ClinicalTrials.gov/show/NCT04032132 |
| Curcumin |
NCT03016039 |
Unknown status |
Not Applicable |
Curcumin Supplementation for Gynecological Diseases |
Curcumin Use for Gynecological Conditions |
https://ClinicalTrials.gov/show/NCT03016039 |
| Curcumin |
NCT03746158 |
Not yet recruiting |
Not Applicable |
Interindividual Variation in Excretion of Curcumin |
Metabolites|Gut Microbiota |
https://ClinicalTrials.gov/show/NCT03746158 |
| Curcumin |
NCT04109742 |
Recruiting |
Phase 2 |
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease |
NAFLD - Nonalcoholic Fatty Liver Disease|NASH - Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT04109742 |
| Curcumin |
NCT04044417 |
Completed |
Phase 4 |
Curcumin-Simvastatin-EDTA in the Treatment of Periodontitis |
Periodontitis |
https://ClinicalTrials.gov/show/NCT04044417 |
| Curcumin |
NCT01811381 |
Active, not recruiting |
Phase 2 |
Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease |
Mild Cognitive Impairment |
https://ClinicalTrials.gov/show/NCT01811381 |
| Curcumin |
NCT04119752 |
Recruiting |
Not Applicable |
The Curcumin Supplement Effect on Saturation Levels of Muscular Oxygen and Vascular Response in Elderly People |
Cardiovascular Risk Factor |
https://ClinicalTrials.gov/show/NCT04119752 |
| Curcumin |
NCT01294072 |
Active, not recruiting |
Phase 1 |
Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue |
Colon Cancer |
https://ClinicalTrials.gov/show/NCT01294072 |
| Curcumin |
NCT01052025 |
Unknown status |
Phase 4 |
Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance |
Type 2 Diabetes|Pre-diabetes|Insulin Resistance|Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT01052025 |
| Curcumin |
NCT01179256 |
Completed |
Not Applicable |
Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma |
Atopic Asthma |
https://ClinicalTrials.gov/show/NCT01179256 |
| Curcumin |
NCT02255370 |
Completed |
Phase 3 |
Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease |
Crohn's Disease |
https://ClinicalTrials.gov/show/NCT02255370 |
| Curcumin |
NCT01246973 |
Completed |
Phase 2|Phase 3 |
Oral Curcumin for Radiation Dermatitis |
Radiation-induced Dermatitis |
https://ClinicalTrials.gov/show/NCT01246973 |
| Curcumin |
NCT02298985 |
Completed |
Phase 4 |
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients |
Chronic Schizophrenia |
https://ClinicalTrials.gov/show/NCT02298985 |
| Curcumin |
NCT04266275 |
Not yet recruiting |
Phase 2 |
Topical Curcumin for HPV Related Cervical Disease |
Neoplasm Cervix |
https://ClinicalTrials.gov/show/NCT04266275 |
| Curcumin |
NCT02369549 |
Active, not recruiting |
Phase 3 |
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease |
Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02369549 |
| Curcumin |
NCT03917784 |
Recruiting |
Phase 4 |
Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes |
PreDiabetes |
https://ClinicalTrials.gov/show/NCT03917784 |
| Curcumin |
NCT01383161 |
Completed |
Phase 2 |
18-Month Study of Memory Effects of Curcumin |
Age-associated Cognitive Impairment|Mild Cognitive Impairment (MCI) |
https://ClinicalTrials.gov/show/NCT01383161 |
| Curcumin |
NCT02978339 |
Completed |
Phase 1|Phase 2 |
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) |
Primary Sclerosing Cholangitis |
https://ClinicalTrials.gov/show/NCT02978339 |
| Curcumin |
NCT01333917 |
Completed |
Phase 1 |
Curcumin Biomarkers |
Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT01333917 |
| Curcumin |
NCT02724202 |
Active, not recruiting |
N/A |
Curcumin in Combination With 5FU for Colon Cancer |
Metastatic Colon Cancer |
N/A |
| Curcumin |
NCT01875822 |
Completed |
Phase 1|Phase 2 |
Open-label Study of Curcumin C-3 Complex in Schizophrenia |
Schizophrenia|Schizoaffective Disorder|Depression |
https://ClinicalTrials.gov/show/NCT01875822 |
| Curcumin |
NCT02554344 |
Unknown status |
Early Phase 1 |
Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) |
Cervical Intraepithelial Neoplasia |
https://ClinicalTrials.gov/show/NCT02554344 |
| Curcumin |
NCT04103788 |
Completed |
Not Applicable |
Evaluation of Increased Absorption of a Curcumin Emulsion (BIOCURC) in Healthy Volunteers |
Bioavailability |
https://ClinicalTrials.gov/show/NCT04103788 |
| Curcumin |
NCT01925287 |
Completed |
Early Phase 1 |
Oral Bioavailability of Curcumin From Micronized Powder and Liquid Micelles in Healthy Young Women and Men |
Pharmacokinetics of Novel Curcumin Formulations|Safety of Novel Curcumin Formulations |
https://ClinicalTrials.gov/show/NCT01925287 |
| Curcumin |
NCT02104752 |
Completed |
Phase 1|Phase 2 |
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia |
Schizophrenia|Cognition|Psychosis |
https://ClinicalTrials.gov/show/NCT02104752 |
| Curcumin |
NCT02439385 |
Completed |
Phase 2 |
Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis |
Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT02439385 |
| Curcumin |
NCT02064673 |
Recruiting |
Phase 3 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02064673 |
| Curcumin |
NCT02474953 |
Completed |
Phase 1 |
A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product |
Healthy |
https://ClinicalTrials.gov/show/NCT02474953 |
| Curcumin |
NCT03953261 |
Recruiting |
Phase 2 |
Effect of Curcumin on Systemic Lupus Erythematosus |
Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03953261 |
| Curcumin |
NCT03262363 |
Unknown status |
Phase 2|Phase 3 |
Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy |
Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Polymorphism |
https://ClinicalTrials.gov/show/NCT03262363 |
| Curcumin |
NCT01982734 |
Completed |
Early Phase 1 |
Improved Oral Bioavailability of Curcumin Incorporated Into Micelles |
Pharmacokinetics of New Curcumin Formulations|Safety of New Curcumin Formulations |
https://ClinicalTrials.gov/show/NCT01982734 |
| Curcumin |
NCT03935958 |
Recruiting |
Not Applicable |
Curcumin in Kidney Transplant Recipients |
Disorder Related to Renal Transplantation |
https://ClinicalTrials.gov/show/NCT03935958 |
| Curcumin |
NCT01403545 |
Completed |
Phase 1 |
Evaluation of Liposomal Curcumin in Healthy Volunteers |
Drug Safety |
https://ClinicalTrials.gov/show/NCT01403545 |
| Curcumin |
NCT01035580 |
Completed |
Phase 1 |
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin |
Uterine Cervical Dysplasia |
https://ClinicalTrials.gov/show/NCT01035580 |
| Curcumin |
NCT01225094 |
Completed |
Phase 2|Phase 3 |
Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair |
Acute Kidney Injury|Abdominal Aortic Aneurysm |
https://ClinicalTrials.gov/show/NCT01225094 |
| Curcumin |
NCT01917890 |
Completed |
Not Applicable |
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer |
Prostate Cancer|Radiation Therapy |
https://ClinicalTrials.gov/show/NCT01917890 |
| Curcumin |
NCT02300727 |
Terminated |
Phase 1|Phase 2 |
Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy |
Mucositis |
https://ClinicalTrials.gov/show/NCT02300727 |
